The assessment of the regenerative capacity of the heart has been compromised by the lack of surface signatures to characterize cardiomyocytes (CMs). Here, combined multiparametric surface marker analysis with single-cell transcriptional profiling and in vivo transplantation identify the main mouse fetal cardiac populations and their progenitors (PRGs). We found that CMs at different stages of differentiation coexist during development. We identified a population of immature heat stable antigen (HSA)/ cluster of differentiation 24 (CD24) + CMs that persists throughout life and that, unlike other CM subsets, actively proliferates up to 1 week of age and engrafts cardiac tissue upon transplantation. In the adult heart, a discrete population of HSA/CD24 + CMs appears as mononucleated cells that increase in frequency after infarction. Our work identified cell surface signatures that allow the prospective isolation of CMs at all developmental stages and the detection of a subset of immature CMs throughout life that, although at reduced frequencies, are poised for activation in response to ischemic stimuli. This work opens new perspectives in the understanding and treatment of heart pathologies.
Introduction
The cell types that form the mammalian heart have diverse developmental origins and temporal differentiation [1] . In the mouse, cardiomyocytes (CMs) are initially specified by embryonic day (E) 7.5 from the first set of cardiogenic progenitors (PRGs; first heart field) [2] followed by the incoming cells from the second heart field (SHF) [3] . At E 9.5 (looping-heart a1111111111 a1111111111 a1111111111 a1111111111 a1111111111 stage), the heart is divided into primitive atria (PAt), primitive ventricle (PVt), and outflow tract (OFT; future great vessels and atrioventricular junction [GV-AVJ]) and is composed of CMs and endocardial cells (EndoCs) that form the endocardium. Cells migrating from the peripheral tissues shape the final heart morphology. From E 9.5 to E 11.0, epicardial cells (EpiCs) derive from the proepicardial organ and coat the heart surface (epicardium). A fraction of EpiCs undergo epithelial-to-mesenchymal transition (EMT), giving rise to epicardialderived cells (EPDCs), which migrate into the myocardium and generate peri-vascular smooth muscle cells (SMCs) [4] and fibroblasts (FBs) [5, 6] . CMs contribute to heart growth [7, 8] through extensive cell divisions and exit the cell cycle as development progresses, a process virtually completed by the end of the first week of postnatal life [9] . The CM compartment enlarges thereafter by hypertrophy that in rodents coincides with binucleation of myocytes [9, 10] .
Several markers have been individually used to identify CMs (signal regulatory protein alpha [SIRPα] , vascular cell adhesion molecule 1 [VCAM-1], Caveolin-3 [Cav3] [11] [12] [13] [17, 18] ), SMCs (platelet derived growth factor receptor beta [PDGFrβ] [19] ) and endothelial cells (ECs, platelet/endothelial cell adhesion molecule 1 [PECAM-1] [20] ). However, because each of these markers is expressed in other cell types, including circulating and heart resident hematopoietic cells, they do not, when used alone, unambiguously define cardiac PRGs or mature populations.
Myocardium regeneration requires the production of new adult CMs. Consistent with a potential regenerative capacity of the adult heart, CM replacement by expansion, albeit at low rate, has been recently reported, indicating that not all adult CMs are postmitotic cells [21, 22] . However, the efforts to unravel mechanisms of neocardiomyogenesis have been hampered by the lack of strategies to identify and prospectively isolate the rare CM capable of turnover in normal and diseased hearts.
To identify different maturation stages of CMs and to follow their development up to adulthood, we analyzed the phenotype of all cells in the developing mouse heart. Multiparametric flow cytometry combined with single-cell multiplex quantitative real time polymerase chain reaction (qRT-PCR) of purified cell subsets allows the identification of distinct cell types and the definition of their lineage affiliation. Heat stable antigen (HSA)/cluster of differentiation 24 (CD24) expression is consistently associated with the CM lineage and, combined with other surface proteins, unraveled coexisting subsets of CMs at different stages of maturation. The most immature population expresses HSA, activated leukocyte cell adhesion molecule (ALCAM), melanoma cell adhesion molecule (MCAM), and troponin T (Tnnt), but not Cav3, and is capable of integrating heart tissue after transplantation. The progressive loss of those surface markers contemporaneous with the expression of Cav3 and binucleation identifies mature CMs. Importantly, HSA + , but not HSA
−

Cav3
+ CM, isolated throughout development and up to postnatal day (P) 7 actively proliferate and spontaneously acquire contractile properties in vitro. Isolated from E15 or from P1, they engraft heart tissue transplanted in the ear pinna of adult mice more efficiently than Cav3 + CMs. HSA + CMs transcriptional profile resembles that of Cav3 + cells, although they express lower levels of transcripts for Gjc1, Arnt, Vim, Actnb, and Casq1 and, in contrast to their Cav3 + counterparts, do not express extracellular matrix transcripts, such as Col3a1. This population that likely corresponds to cells with a stochastic delayed maturation program persists, albeit at low frequencies, in the adult heart and responds to myocardial infarction (MI) by increasing in numbers.
Results
Phenotype assignment to the cellular components in the fetal heart
To resolve the phenotype of the cellular components of the developing heart, we screened by flow cytometry cell suspensions isolated from the 3 heart regions (i.e., At, GV-AVJ-containing the connection of the 4 cavities, the great vessels and the valves-and Vt; Fig 1A) for the expression and relative abundance of 30 surface proteins. The analysis was performed in E 17.5 hearts that have similar structure and cellular components to those observed in the adult. We selected 11 antibodies recognizing surface proteins from which HSA (CD24) had not been previously associated with cardiac cells. Following a sequential gating strategy ( Fig 1A and S1 Fig) , we identified 13 distinct cell populations, after exclusion of hematopoietic (CD45 + Ter119 + ) cells. Multiparametric analysis of the flow cytometry data by nonlinear dimensionality reduction algorithms (Fig 1B) created maps in which cells clustered together according to phenotype (tdistributed stochastic neighbor embedding [t-SNE], upper graphs) or were organized into hierarchies of related phenotypes (spanning tree, lower graphs). Intercellular adhesion molecule 1 (ICAM-1) + cells (olive arrow) were predominant in the At, Sca-1 + (blue arrow), and ALCAM + (cyan asterisk) in the GV-AVJ and Thy1 + (green arrow) in the Vt. The remaining subsets were represented in all 3 regions, although at different frequencies ( Fig 1B) .
To determine the cell identity of the newly defined populations, we analyzed their transcriptional profiles and anatomical distribution. The expression levels of 31 transcripts affiliated to different cardiac lineages were analyzed in purified cells (20 cells) from each subset. Unsupervised hierarchical clustering and principal component analysis (PCA) grouped the subsets in 7 clusters (Fig 2A and 2B and Table 1 ). We observed a strong correlation between the clustering by the transcriptional profiles and the subset definition using the cell surface markers, highlighting the validity and the robustness of our approach. Cluster I encompassed CMs identified by the expression of Nkx2-5, Tnnt2, and Des. At CMs (Cluster Ia) expressed At-specific myosin, Myl7 and Myh6, and were phenotypically characterized by the coexpression of HSA, MCAM, and ALCAM. Vt CMs (Cluster Ib) expressing the Vt myosin Myl2 and Myh7, expressed HSA and MCAM but not ALCAM (Fig 2A and 2B) . We also analyzed the expression and distribution of the identified proteins in situ (Fig 3A) . HSA + CMs identified by the characteristic striated actinin pattern were found in both chambers (more frequent in the At than in the Vt; Fig 3F) (Fig 2A and   2B ), delineating the blood vessels (Fig 3C and 3D ) and the inner surface of the myocardium (EndoC). Cluster IV cells expressed Wt1, Tbx18, S100a4, and Gja1, were identified as ICAM-1 + (Fig 2A and 2B (Fig 3B) , whereas Gp38 + cells were detected in the epicardium (Fig 3E,  � ) .
To probe heterogeneity of the cardiac subsets, we carried out single-cell transcriptional analyses (S2A and S2B Fig) . Cell sorting was performed using the index-sorting tool that records, for each cell, the levels of expression of each phenotypic parameter (S2C Fig). Both the heat map and the PCA analysis indicated that the phenotypically defined populations homogeneously coexpressed the analyzed transcripts, underscoring the strength of this combined approach (S2A and S2B Fig) .
The ensemble of these results validated the phenotyping strategy (Fig 1 and Table 1 ) that allowed the identification (Figs 2A, 2B and 3G) and the prospective isolation of the major cardiac cell subsets in the fetal heart.
Different stages of CM maturation coexist during development
A CM transcriptional profile (Nkx2-5, Tnnt2, and Des) was associated with membrane HSA expression in different, but related, cell populations (Fig 2) isolated from both heart chambers. To understand the kinetics of the newly defined populations along heart morphogenesis, we performed a similar analysis at earlier developmental stages (E 9.5 and E 13. ), initially detected in the E 13.5 Vt, increased to comprise most CMs at E 17.5 ( Fig 4A and S3D  Fig) . Cell cycle analysis showed that E 9. To investigate whether the phenotypically distinct CM subsets corresponded to different stages of maturation, we included Tnnt [23] and Cav3 [12] in our analysis. Surface Cav3 expression is detected in the adult but is undetectable in most immature CMs [12] , whereas Tnnt is widely expressed in the CM lineage [23, 24] . The transcriptional profile of the HSA + CMs along time (E 9.5, E 13.5, and E 17.5) revealed that Cav3 starts to be transcribed at E 9.5 (S2D Fig) , and the first Cav3 + cells detected by protein staining still express high levels of HSA (Fig 4D) , suggesting a lineage relationship between the 2 CM subsets. These results highlight the progressive loss of the surface markers ALCAM, MCAM, and HSA coinciding with the transcriptional expression of Cav3 at E 13.5, whereas at E 17.5 the majority of CMs (Tnnt
+ (Fig 4A) . During maturation, CMs lose proliferative capacity and suffer morphologic alterations leading to increased sarcomere complexity, bigger cell size, and binucleation [9] . Cell-cycle analysis of E 17. Because HSA is the last surface protein to be lost before the acquisition of Cav3, we used these 2 markers to discriminate immature and mature CMs, respectively. Interestingly, HSA and Cav3 expression define 2 CM subsets with different proliferative capacity, even after birth. Three 5-ethynyl-2´-deoxyuridine (EdU) injections (P0, P1, and P2) in the neonates labeled 23% of HSA + CMs detected at P2 and 16% at P4, indicating that this CM subset maintains proliferative activity after birth ( Fig 4C) . By contrast, only 7% of Cav3 + CMs incorporated EdU, demonstrating a lower contribution of the mature CM subset to postnatal heart growth ( Fig  4C) . Other non-CM (stromal) cells showed more than 50% EdU incorporation, compatible with their high proliferative activity at this stage ( Fig 4C) . The reduced frequency of Cav3 To overcome the impaired cell integrity of postnatal CMs, we performed a similar analysis in cells fixed before dissociation. Kinetics of HSA and Cav3 expression showed that the decrease of the former parallels an increase of the latter (S4C Fig) . At E 13.5, we detected HSA + (27.3% ± 3.3%), HSA + Cav3 + (10.3% ± 1.2%), and a few cells expressing Cav3 (10.3% ± 2.6%). At E 17.5, the majority of the cells expressed Cav3 (44.8% ± 6.3%); a fraction of them were binucleated (4.1% ± 0.9%) and coexisted with either HSA + (4.9% ± 1.5%) or HSA were also analyzed by imaging flow cytometry, evidencing decreased percentage of immature HSA + CMs along development (57.8% ± 11.3% at E 13.5 and 38.3% ± 3.8% at E 17.5), with a pronounced decline after birth (4.8% ± 2.3% at P7; Fig 4E) . Importantly, HSA expression was only observed in mononucleated CMs, further associating its expression with an immature phenotype ( Fig 4E) .
To confirm that HSA discriminates immature CM, purified HSA + cells isolated from E 15.5, P2, and P4 hearts were cultured for up to 1 week. E 15.5 HSA + cells either divided (approximately 20%) or were contractile (approximately 75%) in culture, whereas no proliferation was observed in P2 or P4 cardiac cells, probably due to the rapid differentiation in culture ( Fig (Fig 6A and S9C Fig) . Imaging flow cytometry analysis further confirmed the presence of a discrete subset of HSA + Actinin + CMs in adult hearts (0.6% ± 0.33%, n = 3) restricted to the subset of mononucleated CMs smaller (in area and length) than HSA − CMs (Fig 6D) . The HSA + subset was considered as the most immature adult CMs because they shared cytological and phenotypic properties with embryonic CMs, in culture adhered to gelatin-coated plates, survived for a few days, and expressed Tnnt but failed to divide or to contract (S7B Fig), and the majority also coexpressed the mature marker Cav3 (Fig 6A) . Two stromal populations were also discriminated in the adult: (i) a PDGFrα The detection of an immature CM subset in the adult prompted us to investigate its frequency in the diseased heart. We found HSA expression largely circumscribed to the non-CM compartment in sham-operated hearts, although rare HSA + Actinin + CMs were also detected Immature cardiomyocytes are found in the adult heart (outlined by laminin expression, Fig 6C) . Seven days after MI, and in spite of HSA expression associated to the upsurge of the hematopoietic and ECs (S9E Fig), we detected a 3-fold increase in the frequency of HSA + small-round and large-striated mononucleated CMs (# and � , respectively; 4.7% ± 3.6%) compared with sham-operated (1.7% ± 1.1%; Fig 6C) . HSA + CMs were found in the peri-infarcted region as shown in the lower magnification image (Fig 6C) . Moreover, a small percentage of HSA + CMs (i.e., approximately 1 per section) were in cycle (Ki67 expression) after MI (Fig 6C) . A similar increase in HSA + CMs was evidenced after MI by imaging flow cytometry analysis of prefixed cells (1.8% ± 0.3%) compared with sham-operated hearts (0.6% ± 0.15%; Fig 6E) .
Our results show that the cell surface signatures defined for the embryonic heart are suitable to isolate an affiliated adult population. Importantly, we identified a small subset of HSAexpressing adult CMs that, like their embryonic counterparts, are mononucleated, express low levels of Cav3, and exhibit a higher probability than Cav3 + cells to proliferate and increase in frequency after MI.
Discussion
The mouse heart is able to regenerate during the first days of life by proliferation of pre-existing CMs. This capacity is lost after 1 week of postnatal life, the time from which wounded tissue is replaced by a nonfunctional scar [30] . The loss of CM mitotic activity has been attributed to the binucleation process and the complete maturation of CMs that occur after birth [10, 31] . However, recent reports showed that CM replacement and cell division could occur, although at low rate [21, 22] , raising the possibility that a subset of CMs in the adult might undergo mitosis. Specific surface markers need to be identified to allow the isolation and characterization of the low frequency of dividing CMs. We show here that, although HSA is not a marker for proliferating cells, alone it identifies a neonatal CM compartment that retains higher proliferative capacity, persists in the adult, and expands after MI. HSA has been associated with proliferating cells in several tissues (e.g., skeletal muscle PRG cells [32, 33] ), as well as in several cancer types [34] ; however, its function is unknown. Although HSA is detected in all CMs in E 9.5 (S5C Fig) , the constitutive inactivation of HSA does not appear to have a strong impact in heart development, because these mice are viable and fertile. It has, however, been reported that the fraction of born homozygous pups is lower than predicted, raising a possibility of a low penetrance lethal effect [32] . Expression of Isl1, Gata4, Mef2c, and Tbx20 is important for CM commitment and initial stages of differentiation [35] [36] [37] , and accordingly they were used as indicative of the CM lineage. Consistent with previous reports [29] , we found some of these transcripts also expressed during the development of stromal cells (SMCs and FBs), suggesting that, in the heart, they participate in the development of different lineages. These findings demonstrate that CMs can only be unambiguously identified by the combined expression of transcription factors, transcripts codifying structural and contractile proteins, and by the absence of stromal-or ECassociated markers.
Several studies identified CM PRGs based on the expression of Sca-1 and c-kit [14] [15] [16] cellsurface proteins, which in our work were not found within the CM compartment. c-kit was only expressed in ECs (PECAM-1 + ), as recently shown also by others [38] , and in Thy1 + PDGFrα + FBs. Sca-1 expression was detected in a fraction of ECs and in a population of cells in the atrioventricular canal in the fetal heart and in the interstitium of adult myocardium [15] . Their spatial pattern and transcriptional profile are compatible with an FB lineage affiliation, supported by the description of Sca-1-expressing cells exhibiting a paracrine role in angiogenic stimulation after MI [15, 39] . At E 9.5, we found an HSA, ALCAM, and PDGFrα expressing population that was highly proliferative and expressed Nkx2-5 and Tnnt2 together with Isl1 and Tbx5, suggesting they represent CM PRGs (S2D Fig) [40, 41 ]. These cells sharply decrease in frequency, they are only detected in the At after E13.5 of development, and become undetectable after birth, a finding that is not compatible with the persistence of CM PRGs in the postnatal heart. We identified HSA, so far never associated to heart development or maturation, as a transversal marker of immature CMs throughout life. Our analysis showed a continuum in CM maturation, which is an asynchronous and apparently stochastic process that starts during development and can be prospectively identified by the expression of distinct surface markers (Fig 7) . Immature CMs can be identified by a unique phenotype, i.e., HSA ) that decrease in frequency, coinciding with an increase in noncycling and binucleated Cav3 + CMs that compose the myocardium in adulthood. These results are in agreement with alterations endured by CMs during the first week of life, which encompass a transition from hyperplasia to hypertrophy and terminal differentiation [9, 10] . This is also consistent with the higher expression of transcripts specific for cardiac structural proteins found at the single-cell level of Cav3 + postnatal compared with HSA + CMs.
By contrast, Col3a1 that characterizes a recently described population of ECM expressing CMs detected after E 14.5 [28] was found in the present study in Cav3 + cells that we likewise also first detect after E13.5. Interestingly, a higher frequency of immature HSA + CMs (>70%) maintain cell integrity, after enzymatic digestion, compared with Cav3 + CMs (<4%). The observation that different subsets of postnatal CMs have different degrees of cell viability after enzymatic digestion is an important piece of information that impacts experiments performed with CM cell suspensions. Immature cardiomyocytes are found in the adult heart A subset (<1%) of adult CMs displayed HSA and remained mononucleated, thus resembling embryonic CM, despite expressing Cav3 at the cell surface. Postnatal and adult HSA + cells share the same morphological features of immature CMs (small, round shaped and mononucleated). However, adult HSA + CMs did not acquire spontaneous contractility in culture, indicating that they are less resistant than perinatal immature CMs to dissociation and thus more similar to Cav3 + CMs. Our findings are in line with previous reports showing low rates of cell division (0.76% [21] and 0.3% to 1% [42] per year) in small, mononucleated, and diploid CMs in the adult heart. Foreseeing its therapeutic relevance, we tested whether HSA + immature CMs could respond to a pathological challenge. We observed an upsurge in the frequency of adult mononucleated HSA + CMs 7 days after MI (from 0.6% to 1.8%). This relative increase in HSA + CMs can be explained by proliferation, detected at very low frequency in our analysis, by increased resistance of HSA + CMs to hypoxia, by re-expression of HSA or by any combination of the above. In the developing heart, low oxygen tension is found in the compact myocardial layer [43] precisely where immature HSA + CMs were found in this study. An adult CM subset protected from oxidative stress in hypoxic niches and exhibiting low proliferative activity upon injury has been recently identified. Similar to HSA + CMs, these cells were mononucleated, small sized, and represented around 1% of the adult myocardium [42] . Although we have not found differences in the hypoxia regulated transcripts at steady state, we cannot rule out that both cell types might respond differently to ischemia. Although HSA + immature CMs do not proliferate sufficiently to regenerate the myocardium, they might account for the low CM turnover rate previously described in the adult [21, 22, 44] and might be more amenable than binucleated CMs to respond to mitotic stimuli. Importantly, using the strategy herein described, CMs at different maturation stages can now be prospectively isolated as viable cells from the adult heart, enabling further mechanistic studies.
Materials and methods
Ethics statement
All animal manipulations at i3S were approved by the Animal Ethics Committee and Direcção-Geral de Veterinária-DGAV; at Pasteur Institute, animal manipulations were approved by the Ethics Committee and by the French Agriculture ministry according to the Ethic Chart and the European Parliament Directive 2010/63/EU at both institutes.
Mice
C57BL/6 mice (Charles River) 6 to 8 weeks old or timed pregnant females were used. Timed pregnancies were generated after overnight mating. The following morning, females with vaginal plug were considered to be at E 0.5. Ub-GFP mice used for transplantation experiments were a kind gift from P. Bousso (Pasteur Institute) [45] .
Mouse model of MI
MI was experimentally induced by permanent ligation of the left coronary artery as previously described by Nascimento and colleagues [46] , and samples were analyzed 7 days after injury.
Transplantation of Ub-GFP or CFSE + cells in embryonic cardiac implants (ear-pinna model)
As shown in S8A Fig, E 15 .5 cardiac Vt from WT embryos were dissected and grafted in the ear pinna of recipient adult WT mice, under anesthesia, as previously described by Ardehali and colleagues [26] . Seven days later, hearts from Ub-GFP (E 15. 
. After isolation, WT cells (E 15.5 or P1) were labeled with CFSE (Molecular Probes, C1157) as previously described by Tario and colleagues [27] . One week later, the implants were collected, and tissue was processed for immunofluorescence as described below.
Isolation of live cardiac cells
Embryonic hearts were collected under a stereomicroscope, and the 3 anatomic heart structures (At, GV-AVJ, and Vt) were microdissected. Heart tissue was minced into 1 mm 3 fragments and incubated for 15 minutes at 37˚C in the enzymatic solution: for E 13.5 and E 17. , and filtered with a 70 μm mesh strainer (Fisher Scientific).
Isolation of fixed CMs
Fixed CMs were isolated as described by Mollova and colleagues [47] with some alterations. E 13.5, E 17.5, P7, adult, and injured (MI or sham-operated) hearts were collected, washed in PBS (to remove blood, Invitrogen), minced into 2 mm 3 pieces, flash frozen in liquid nitrogen, and stored at −80˚C. For cell isolation, tissue pieces were fixed in 4% paraformaldehyde (Electron Microscopy Sciences) at room temperature for 2 hours, washed in PBS for 5 minutes, and digested with 3 mg/ml collagenase type II (Worthington) in HBSS on a rotator at 37˚C until no macroscopic tissue was detected. Enzyme activity was blocked with 10% FBS-HBSS (Life Technologies). Cell suspensions were filtered through a 100-μm cell strainer (Fisher Scientific).
Flow cytometry, cell sorting, and imaging flow cytometry
Heart-cell suspensions were stained with (conjugated or nonconjugated) antibodies (20 minutes, 4˚C in the dark) followed by incubation with conjugated streptavidin (10 minutes, 4˚C in the dark). Whenever using a nonconjugated antibody, a sequential incubation with a secondary antibody was performed for 15 minutes at 4˚C in the dark (see S1 Table for the antibodies list). PI (1μg/ml) was used to exclude dead cells. In designated experiments of postnatal hearts, cells were incubated with Hoechst 33342 (0.2 μg/ml, Molecular Probes H3570) in 2% FBS-HBSS for 30 minutes at 37˚C. Intracellular proteins (Ki67 and troponin) detection was performed after surface staining, and fixation and permeabilization with the Foxp3/Transcription Factor Staining Buffer Set (eBioscience, USA). DAPI (1/10000, Molecular Probes) was used to stain DNA in fixed cells (5 minutes at 4˚C). EdU staining was also performed after surface staining, fixation, and permeabilization with the Click-it EdU flow cytometry assay kit Fixed CMs were resuspended in BD Cytofix/Cytoperm Fixation/Permeabilization Kit (BD Biosciences), permeabilized in BD Perm/Wash buffer for 15 minutes, incubated with primary antibodies for 2 hours at 4˚C, and incubated with Alexa Fluor-conjugated secondary antibodies for 30 minutes at 4˚C. Prior to acquisition on ImageStream, nuclei were stained with 20 μM DRAQ5 (Biostatus, UK) and filtered with 100-μm cell strainer (Fisher Scientific). Data acquisition was performed using an Amnis ImageStreamX cytometer (Luminex). Files were collected with a cell classifier applied to the bright-field (BF) channel to capture events larger than 20 μm and included BF, FITC, PECy7, and DRAQ5 images. At least 30,000 cells were analyzed for each sample, and all images were captured with the 40× objective. Data analysis was performed with IDEAS software (version 6.0, Luminex). For each sample, only intact CMs, selected based on Actinin and DRAQ5 signal intensity, were considered for subsequent analysis. For the morphometric analysis, we applied a morphology mask to the BF channel, and for assessment of the number of nuclei per cell, we used the DRAQ5 images. 
Culture and live-cell imaging
Histological processing and immunofluorescence staining
Embryonic and adult (MI and sham-operated) hearts were fixed in 0.2% paraformaldehyde (Merck) overnight at 4˚C, dehydrated in a sucrose gradient (4% followed of 15%), embedded in gelatin, and frozen. Tissue cryo-sections (4 μm thick) were blocked with either 4% FBS-1% BSA blocking solution or Vector M.O.M. basic kit (Vector Laboratories), depending on the specific conditions detailed in S2 Table. Tissue sections were incubated with primary antibodies overnight at 4˚C, followed by 1-hour incubation with Alexa Fluor-conjugated secondary antibodies (see S2 Table for the antibodies list; Invitrogen). Slides were mounted, and nuclei were counterstained with aqueous mounting medium with DAPI (Vector Laboratories). Representative high-resolution images were acquired for each heart structure (At, GV-AVJ, and Vt) at 40× magnification in a confocal microscope (Leica SP5II, Leica, Germany). Wholeheart acquisitions were obtained using the high-content imaging system (IN Cell Analyzer 2000, GE Healthcare). Isolated fixed CMs were resuspended in 10% FBS-PBS and spun onto superfrost slides in a cytocentrifuge (ThermoFisher). Cytospins were incubated with primary antibodies overnight at 4˚C, followed by 1-hour incubation with Alexa Fluor-conjugated secondary antibodies. Acquired images were edited and quantified using the Image J version 1.51d software (NIH).
Gene expression analysis
Sorted cells in RT-STA Reaction mix from the CellsDirectTM One-Step qRT-PCR Kit (Life Technologies) were kept at −80˚C at least overnight before reverse transcription and specific target pre-amplification (20 cycles for single cells and 18 cycles for 20 cells). Pre-amplified samples were subjected to qRT-PCR (see S3 Table for Taqman assays list, Applied Biosystems) as previously described by Chea and colleagues [49] .
Bioinformatic analysis
Flow cytometry data analysis was performed in FCS files of live CD45
− cell fraction using R package flowCore from R version 3.2.4 revised (2016-03-16 r70336) and the interface R Studio version 0.99.467 (R foundation) [50] . Subsequently, gating, as described in Fig 1  and in S1 Fig, was used to define each population. Map clustering of the flow cytometry data was performed using custom R scripts from R package t-SNE to dimensionality reduction − t-SNE (R foundation) [51] and Bioconductor.org package flowSOM to visualize Self-Organizing and Minimal Spanning Trees (Spanning Trees, R foundation) [52, 53] . Gene expression raw data (BioMark Fluidigm, Applied Biosystems) of sorted cells at the population level was normalized with HPRT, and data are presented in 2 −ΔCt . Single-cell gene expression analysis was performed in cells that expressed at least 1 of 3 housekeeping genes (Hprt, Gapdh, or Actb), and Ct values were used to the following analysis. A Ct value of 21 was the maximum value considered as expressed gene, and the background (i.e., nondetected) Ct value was 38. qRT-PCR data were processed with the QLUCORE (Qlucore AB 2008-2015, Sweden) software, and pheatmap package (version 1.0.10) R (R version 3.5.0, R foundation) was displayed in uncentered Pearson's correlation unsupervised hierarchical clustering and PCA either for surface phenotype or transcripts.
Statistical analysis
All results are shown as mean ± SD. Statistical significance was determined using the Student t test, except when comparing the frequency of HSA + CMs from E 13.5 to P7 (one-way ANOVA followed by Tukey test). The statistical analysis of the data was performed using SigmaPlot software (p < 0.05 was considered statistically significant, R foundation) or QLUCORE (Qlucore AB 2008-2015, Sweden) software for the multidimensional analysis of multiplex qRT-PCR (two-way ANOVA, p = 0.007, q = 0.01). , bottom left quadrant, green). Contour plots display E 9.5 whole-heart cells and E 13.5 and E 17. 
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